Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart

Financials

Date Filing Description Download
12/23/11 4 Statement of Changes in Beneficial Ownership
12/21/11 8-K Current report filing
12/19/11 3 Initial Statement of Beneficial Ownership
12/07/11 8-K Current report filing

Stock Quote

ACOR (Common Stock) $ 3.12 -0.06 (-1.89%) Volume: 1,225,586 MORE August 23, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.